Articles by tag: langlara

FDA approved Langlara as an interchangeable biosimilar of insulin glargine

FDA granted Langlara interchangeable biosimilar status to Lantus. Learn how this will change the US insulin market and expand patient access to therapy.

Langlara: FDA approved Chinese insulin biosimilar

FDA approved interchangeable biosimilar insulin glargine Langlara from Chinese Sunshine Lake. Learn how this will change the US market and prices for patients. Detailed analysis inside.